Johnson & Johnson vs Stryker Corporation — Stock Comparison
Johnson & Johnson (JNJ) and Stryker Corporation (SYK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Stryker Corporation scores ahead of Johnson & Johnson on Q·Score (8 vs 7 out of 10), led by Growth (8.2 vs 5) and Valuation (8.6 vs 6.5). Johnson & Johnson scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for SYK (+34.7%) than for JNJ (+3.7%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 26% return on equity and 21% profit margins.
⚠ earnings contracting 1% year-over-year.
Consensus analyst target of $374.88 is 35% above current price.
Analyst Consensus
Fundamentals
Frequently Asked Questions
JNJ vs SYK: which stock scores better overall?
Based on Q·Score, Stryker Corporation (SYK) scores 8/10 versus Johnson & Johnson (JNJ) at 7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: JNJ or SYK?
Stryker Corporation (SYK) scores higher on Growth (8.2/10 vs 5/10). Johnson & Johnson reports revenue growth (6.6% YoY) while Stryker Corporation reports (9.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is JNJ or SYK more attractively valued?
Stryker Corporation (SYK) scores higher on Valuation (8.6/10 vs 6.5/10). JNJ trades at 21.8× P/E versus SYK at 16.6×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about JNJ vs SYK?
There are 22 analysts covering JNJ with a consensus price target of $277.91, and 25 analysts covering SYK with a consensus target of $374.88. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: JNJ or SYK?
Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 7.7/10). Net profit margin: JNJ at 21.5%, SYK at 14.4%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: JNJ or SYK?
Stryker Corporation (SYK) scores higher on Financial Health (7.4/10 vs 6.5/10). Market beta: JNJ at 0.23, SYK at 0.77. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of JNJ and SYK?
Johnson & Johnson (JNJ) has a market capitalisation of $645.9B, while Stryker Corporation (SYK) has a market cap of $106.8B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do JNJ or SYK pay dividends?
JNJ pays a dividend yield of 1.98%, while SYK pays a dividend yield of 1.26%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →